Entry Point Capital, LLC Ptc Therapeutics, Inc. Put Options Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PTCT
# of Institutions
222Shares Held
78.1MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$394 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$341 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$336 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$320 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$313 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.09B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...